ARVN
ArvinasCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The post-print bull read is that first-in-class PROTAC approval plus the planned Rigel handoff lets Arvinas redirect focus toward ARV-102, ARV-806 and ARV-393 while cash runway guidance extends into 2H28 [#8-K-2026-05-12]. Secondary reaction was constructive: StockAnalysis showed BofA raising its target to $16 from $14, BTIG to $18 from $16, and Barclays to $20 from $18 after the update.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +11.1.
What can break
ARV-102’s next step in PSP is explicitly pending FDA feedback, so delay or narrower trial scope would pressure one of the cleanest 2H26 catalysts.
Momentum
8
Value
57
Sentiment
90
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $11.00 · Bull $15.50 · Bear $6.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $14.38
Why
Momentum8 · Δ7d -2.3
Value57 · Δ7d +0.1
Sentiment90 · Δ7d +11.1
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
8
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.3
Δ21d
-1.3
Value
57
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
90
33% active weight
Current posture
7d trendImproving
Δ7d
+11.1
Δ21d
+1.5
Why this grade
Composite grade C. Momentum 8.4 / Value 56.9 / Sentiment 89.8
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$553.59M
Beta
1.88
Shares Out
64.22M
P/E (TTM) · Derived
-7.6
P/S (TTM)
2.30
P/FCF (TTM) · Derived
-1.90
Rev YoY
-59.1%
EPS YoY
+29.7%
Gross Margin
-
Op Margin
-32.7%
Net Debt
-$1.04B
Current Ratio
5.70
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology